NHHS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NHHS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, NorthStar Healthcareome's PE Ratio without NRI is 0.00. NorthStar Healthcareome's 5-Year EBITDA growth rate is 0.00%. Therefore, NorthStar Healthcareome's PEG Ratio for today is N/A.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for NorthStar Healthcareome's PEG Ratio or its related term are showing as below:
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
The historical data trend for NorthStar Healthcareome's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NorthStar Healthcareome Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
PEG Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
- | - | - | - | - |
NorthStar Healthcareome Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
PEG Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
For the REIT - Healthcare Facilities subindustry, NorthStar Healthcareome's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the REITs industry and Real Estate sector, NorthStar Healthcareome's PEG Ratio distribution charts can be found below:
* The bar in red indicates where NorthStar Healthcareome's PEG Ratio falls into.
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.
NorthStar Healthcareome's PEG Ratio for today is calculated as
PEG Ratio | = | PE Ratio without NRI | / | 5-Year EBITDA Growth Rate* |
= | / | 0.00 | ||
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
NorthStar Healthcareome (OTCPK:NHHS) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Thank you for viewing the detailed overview of NorthStar Healthcareome's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Ann Harrington | officer: General Counsel and Secretary | C/O COLONY NORTHSTAR, INC., 590 MADISON AVENUE, 34TH FLOOR, NEW YORK NY 10022 |
Kendall K Young | officer: CEO and President | 3760 KILROY AIRPORT WAY, SUITE 300, LONG BEACH CA 90806 |
Nicholas Balzo | officer: Chief Financial Officer | 201 COMMONS PARK S, UNIT 502, STAMFORD CT 06902 |
Paul Varisano | officer: Chief Financial Officer | 590 MADISON AVENUE, 34TH FLOOR, NEW YORK NY 10022 |
Neale Redington | officer: Chief Financial Officer | C/O COLONY NORTHSTAR, INC., 515 S. FLOWER ST., 44TH FLOOR, LOS ANGELES CA 90071 |
Jonathan A. Carnella | director | C/O NORTHSTAR HEALTHCARE INCOME, INC., 590 MADISON AVENUE, 34TH FLOOR, NEW YORK NY 10022 |
Richard S. Welch | director, officer: Chairman | C/O COLONY NORTHSTAR, INC., 515 S. FLOWER STREET, LOS ANGELES CA 90071 |
Smith Jack Fleming Jr. | director | C/O NORTHSTAR REALTY FINANCE CORP., 399 PARK AVENUE, 18TH FLOOR, NEW YORK NY 10022 |
Gregory A Samay | director | C/O NORTHSTAR HEALTHCARE INCOME INC, 399 PARK AVE 18TH FLOOR, NEW YORK NY 10022 |
Thomas Andrew Smith | director | 111 WESTWOOD PLACE, SUITE 400, BRENTWOOD TN 37027 |
Justin T Chang | director, officer: Chairman | 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102 |
Daniel Joseph Altobello | director | 6550 ROCK SPRING DR, SUITE 550, BETHESDA MD 20817 |
Robert C Gatenio | director, officer: Vice Chairman | C/O COLONY NORTHSTAR, INC., 590 MADISON AVENUE, 34TH FLOOR, NEW YORK NY 10022 |
Frank V Saracino | officer: CFO and Treasurer | 399 PARK AVENUE, 18TH FLOOR, NEW YORK NY 10022 |
Ronald J Jeanneault | officer: CEO and President | C/O NORTHSTAR HEALTHCARE INCOME, INC., 399 PARK AVENUE, 18TH FL, NEW YORK NY 10022 |
From GuruFocus
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.